Panelists discuss how pharmacists play a vital role in ensuring personalized care for tardive dyskinesia patients by fostering continuous, secure communication and collaboration with health care teams across various practice settings.

administrator
Related Articles
IMS 2025: Quadruplet Regimens Enhance Depth of Response…
- September 18, 2025
IMS 2025: Future Directions for CAR T Therapy…
- September 17, 2025